
Results
46
High return on equity, past performance and sound balance sheet.
46 companies
Limbach Holdings
Market Cap: US$1.0b
Operates as a building systems solution company in the United States.
LMB
US$82.48
7D
0.9%
1Y
-18.2%
Harmony Biosciences Holdings
Market Cap: US$2.2b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$37.32
7D
1.3%
1Y
-5.2%
Global Industrial
Market Cap: US$1.2b
Through its subsidiaries, operates as an industrial distributor of various industrial and maintenance, repair, and operation (MRO) products in the United States and Canada.
GIC
US$32.60
7D
8.6%
1Y
34.9%
Applied Industrial Technologies
Market Cap: US$10.2b
Distributes industrial motion, power, control, and automation technology solutions in the United States, Canada, Mexico, Australia, New Zealand, Singapore, and Costa Rica.
AIT
US$289.94
7D
13.1%
1Y
9.4%
Pegasystems
Market Cap: US$6.8b
Develops, markets, licenses, hosts, and supports enterprise software in the United States, rest of the Americas, the United Kingdom, rest of Europe, the Middle East, Africa, and the Asia-Pacific.
PEGA
US$39.26
7D
-20.4%
1Y
-27.6%
Vita Coco Company
Market Cap: US$3.3b
Develops, markets, and distributes coconut water products under the Vita Coco brand name in the United States, Canada, Europe, the Middle East, Africa, and the Asia Pacific.
COCO
US$55.00
7D
1.5%
1Y
48.3%
Market Cap: US$14.0b
Operates as a visual search and discovery platform in the United States, Canada, Europe, and internationally.
PINS
US$19.87
7D
-11.9%
1Y
-40.3%
ResMed
Market Cap: US$36.6b
Develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally.
RMD
US$263.03
7D
2.1%
1Y
8.4%
Stride
Market Cap: US$3.6b
Provides proprietary and third-party online curriculum, software systems, and educational services in the United States and internationally.
LRN
US$86.45
7D
4.5%
1Y
-37.6%
ACADIA Pharmaceuticals
Market Cap: US$4.2b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$24.23
7D
-5.4%
1Y
23.6%